CaMKs coordinated with mTOR pathway-related gene expression and improved UCH-L1 level to favor for tyrosine hydroxylase and clear abnormal α-synuclein, thereby delaying neurodegeneration or improving the pathogenesis of PD lesions. Here, UCHL1 is linked to Parkinson disease.